The effect of Ru-Vert and its components on post-rotatory motor performance.
D000328:Adult; D002986:Clinical Trials as Topic; D003654:Deceleration; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D010433:Pentylenetetrazole / Q000009:adverse effects / Q000627:therapeutic use*; D010632:Pheniramine / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D012399:Rotation; D013997:Time Factors; D014717:Vertigo / Q000188:drug therapy*
D004338:Drug Combinations; D009539:Nicotinic Acids; D010919:Placebos; D010632:Pheniramine; C009193:Ru-Vert; D010433:Pentylenetetrazole